Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GVAX in Advanced Bronchioloalveolar Carcinoma
NCT00074295Phase 2Terminated
- Sponsor
- SWOG Cancer Research Network
- Start
- Mar 2004
- Primary completion
- Aug 2007
- Modality
- Bone Marrow HSCs, HLA-independent TCR-T, Vaccines & Immunotherapeutics
01
Overview
A Phase 2 trial of CG8123 in bronchioloalveolar carcinoma (BAC), sponsored by SWOG Cancer Research Network. Started Mar 2004; status: terminated.
02
Drugs
CG8123
03
Conditions
bronchioloalveolar carcinoma (BAC)
Beyond the preview
Go deeper on NCT00074295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00074295.